Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shree Pacetronix's FCF Margin % or its related term are showing as below:
BOM:527005'
s FCF Margin % Range Over the Past 10 Years
Min: -12.8 Med: 3.29 Max: 14.68
Current: 7.98
During the past 13 years, the highest FCF Margin % of Shree Pacetronix was 14.68%. The lowest was -12.80%. And the median was 3.29%.
BOM:527005's FCF Margin % is ranked better than 69.99% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: -0.74
vs BOM:527005: 7.98
The historical data trend for Shree Pacetronix's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:527005 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Shree Pacetronix's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Pacetronix FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shree Pacetronix's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Shree Pacetronix's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shree Pacetronix (BOM:527005) has a FCF Margin % of 0.00% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shree Pacetronix and its competitors. According to the industry distribution chart, Shree Pacetronix ranks #244 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 30%.
Is Shree Pacetronix's FCF Margin % too high?
Shree Pacetronix's current FCF Margin % is 0.00%. Based on the distribution chart, Shree Pacetronix ranks #244 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shree Pacetronix has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shree Pacetronix's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shree Pacetronix ranks #244 out of 813 companies for FCF Margin %. This puts Shree Pacetronix in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shree Pacetronix and its competitors. Shree Pacetronix's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Pacetronix stock overvalued right now?
Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹153.10, compared to a current price of ₹137.40 — trading 10.3% below its estimated fair value. The current FCF Margin % is 0.00%. Shree Pacetronix's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current FCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Pacetronix (BOM:527005) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Pacetronix stock appears to be undervalued.
The current stock price of ₹137.40 is trading 10.3% below its estimated GF Value™ of ₹153.10.
GuruFocus considers Shree Pacetronix to be Modestly Undervalued.
Key valuation signals for BOM:527005:
FCF Margin %: 0.00%
GF Value™: ₹153.10 vs. price of ₹137.40 (10.3% below fair value)
No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.
80GF Score
Get the complete analysis for BOM:527005
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:527005 has been successfully added to your 
